False
October 1, 2026
3 min read
Cellares Co-Founder and CEO discusses why the future of cell therapy depends on rethinking how therapies are made
September 30, 2026
10 min read
How direct T-cell reprogramming could simplify CAR-T manufacturing, expand patient access, and extend cellular immunotherapy to new indications
September 29, 2026
5 min read
Coordinated development and practical testing pathways can help ensure eligible patients are identified from the point of approval
September 28, 2026
3 min read
Phase I study will test whether a targeted lentiviral vector can generate BCMA-directed CAR T cells inside patients with multiple myeloma
False